Logo image of CERC

Cerecor Inc (CERC) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CERC -

2.93
-0.05 (-1.68%)
Last: 8/25/2021, 8:25:06 PM
2.9468
+0.02 (+0.57%)
After Hours: 8/25/2021, 8:25:06 PM
Fundamental Rating

2

Overall CERC gets a fundamental rating of 2 out of 10. We evaluated CERC against 190 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of CERC have multiple concerns. CERC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • CERC had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -119.98%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -1201.64%
PM (TTM) -1194.83%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

  • There is no outstanding debt for CERC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

  • Based on the Altman-Z score of -4.37, we must say that CERC is in the distress zone and has some risk of bankruptcy.
  • A Debt/Equity ratio of 0.79 indicates that CERC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Altman-Z -4.37
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

  • A Current Ratio of 2.19 indicates that CERC has no problem at all paying its short term obligations.
  • A Quick Ratio of 2.18 indicates that CERC has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 2.18

More info and screens

3

3. Growth

3.1 Past

  • The earnings per share for CERC have decreased strongly by -49.12% in the last year.
  • CERC shows a decrease in Revenue. In the last year, the revenue decreased by -6.39%.
  • Measured over the past years, CERC shows a very negative growth in Revenue. The Revenue has been decreasing by -37.78% on average per year.
EPS 1Y (TTM)-49.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.26%
Revenue 1Y (TTM)-6.39%
Revenue growth 3Y-37.78%
Revenue growth 5YN/A
Sales Q2Q%150.78%

3.2 Future

  • Based on estimates for the next years, CERC will show a small growth in Earnings Per Share. The EPS will grow by 7.94% on average per year.
  • The Revenue is expected to grow by 120.79% on average over the next years. This is a very strong growth
EPS Next Y4.09%
EPS Next 2Y11.13%
EPS Next 3Y16.75%
EPS Next 5Y7.94%
Revenue Next Year-12.27%
Revenue Next 2Y17.22%
Revenue Next 3Y104.26%
Revenue Next 5Y120.79%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CERC Yearly Revenue VS EstimatesCERC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
CERC Yearly EPS VS EstimatesCERC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 -0.5 -1 -1.5 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • CERC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CERC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CERC Price Earnings VS Forward Price EarningsCERC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -3.42
CERC Per share dataCERC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CERC's earnings are expected to grow with 16.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.13%
EPS Next 3Y16.75%

More info and screens

0

5. Dividend

5.1 Amount

  • CERC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Cerecor Inc

NASDAQ:CERC (8/25/2021, 8:25:06 PM)

After market: 2.9468 +0.02 (+0.57%)

2.93

-0.05 (-1.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.01%
Inst Owner Change0%
Ins Owners3.95%
Ins Owner Change0%
Market Cap281.31M
Revenue(TTM)6.43M
Net Income(TTM)-76.89M
Analysts100
Price Target6.63 (126.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 43.72
P/FCF N/A
P/OCF N/A
P/B 13.03
P/tB N/A
EV/EBITDA -3.42
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.67
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.07
BVpS0.22
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -119.98%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -1201.64%
PM (TTM) -1194.83%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.19
Quick Ratio 2.18
Altman-Z -4.37
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.26%
EPS Next Y4.09%
EPS Next 2Y11.13%
EPS Next 3Y16.75%
EPS Next 5Y7.94%
Revenue 1Y (TTM)-6.39%
Revenue growth 3Y-37.78%
Revenue growth 5YN/A
Sales Q2Q%150.78%
Revenue Next Year-12.27%
Revenue Next 2Y17.22%
Revenue Next 3Y104.26%
Revenue Next 5Y120.79%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Cerecor Inc / CERC FAQ

What is the ChartMill fundamental rating of Cerecor Inc (CERC) stock?

ChartMill assigns a fundamental rating of 1 / 10 to CERC.


What is the valuation status of Cerecor Inc (CERC) stock?

ChartMill assigns a valuation rating of 0 / 10 to Cerecor Inc (CERC). This can be considered as Overvalued.


How profitable is Cerecor Inc (CERC) stock?

Cerecor Inc (CERC) has a profitability rating of 0 / 10.


Can you provide the financial health for CERC stock?

The financial health rating of Cerecor Inc (CERC) is 2 / 10.


Can you provide the expected EPS growth for CERC stock?

The Earnings per Share (EPS) of Cerecor Inc (CERC) is expected to grow by 4.09% in the next year.